Researchers from the University of Birmingham (UoB) and the University of Naples Federico II have found that a sequence of ...

Johnson & Johnson (J&J) has shared positive results from a phase 3b study of Tremfya (guselkumab) in adults with psoriatic ...

Psoriatic arthritis represents a complex intersection of immune dysfunction where inflammation targets both skin and joints, ...

Psoriatic arthritis is a combination of psoriasis and arthritis symptoms. You may have skin and nail changes, joint pain and ...

In individuals with psoriasis, the immune system malfunctions, causing inflammatory cells to accumulate in the dermis, the ...

Long-term extension data show Tremfya (guselkumab) significantly reduced symptoms and inhibited structural joint damage ...

Long-term extension analysis of the phase 3b APEX study (NCT04882098) through 3 years of treatment will further assess the sustained efficacy of guselkumab (Tremfya; Johnson & Johnson) in limiting ...

Johnson & Johnson announces positive results from phase 3b APEX study of Tremfya to treat adults living with active psoriatic arthritis: Spring House, Pennsylvania Monday, April 7 ...

This means that its product packaging is easy for everyone to open, close, hold and apply — and ideal for people with ...

Learn how food, movement, stress relief, and gut health can help regulate inflammation and support long-term wellness.

Scientists are urging quicker diagnosis and treatment of psoriatic arthritis to prevent long-term harm to patients. Psoriatic ...

Your fingers can also peel due to sunburn and some types of ... causing skin cells to multiply too quickly. There is no cure for psoriasis, so treatment centers on managing symptoms. For mild to ...